# Casdin Capital, LLC 13F holdings Q2 2026: $2 billion

Casdin Capital, LLC reported $2 billion in 13F securities across 43 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Revolution Medicines Inc at $483 million, 24.2% of the reported value. Since Q1 2026 it opened 6 new positions and exited 3.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $1,997,798,996
- Positions: 43
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1534261
- Form 13F file number: 028-17113
- CRD number: 169579
- Business address: 1350 Avenue of the Americas Suite 2600, New York, NY 10019
- SEC filing: [0000919574-26-005491](https://www.sec.gov/Archives/edgar/data/1534261/000091957426005491/0000919574-26-005491-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/casdin-capital-llc-169579)

## Top 25 holdings by value

The largest of 43 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 2,577,333 | $482.7 million | No change |
| [Relay Therapeutics Inc](https://specstream.ai/data/institutional-holders/relay-therapeutics-inc-75943r102) | COM | 16,035,240 | $300 million | +1,616,666 |
| [Genedx Holdings Corp](https://specstream.ai/data/institutional-holders/genedx-holdings-corp-81663l200) | COM CL A | 3,707,164 | $254.5 million | +700,000 |
| [Biolife Solutions Inc](https://specstream.ai/data/institutional-holders/biolife-solutions-inc-09062w204) | COM NEW | 4,655,000 | $131.5 million | -1,302,165 |
| [Illumina Inc](https://specstream.ai/data/institutional-holders/illumina-inc-452327109) | COM | 530,000 | $93.2 million | No change |
| [Standard Biotools Inc](https://specstream.ai/data/institutional-holders/standard-biotools-inc-34385p108) | COM | 88,783,856 | $73 million | No change |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 1,175,000 | $63.1 million | No change |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 2,045,000 | $52.6 million | +205,000 |
| [Neurogene Inc](https://specstream.ai/data/institutional-holders/neurogene-inc-64135m105) | COM | 1,545,361 | $48.6 million | +125,000 |
| [Beam Therapeutics Inc](https://specstream.ai/data/institutional-holders/beam-therapeutics-inc-07373v105) | COM | 1,350,000 | $46.3 million | No change |
| [10x Genomics Inc](https://specstream.ai/data/institutional-holders/10x-genomics-inc-88025u109) | CL A COM | 1,050,000 | $40.3 million | -1,225,000 |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 665,000 | $36.6 million | +315,000 |
| [Personalis Inc](https://specstream.ai/data/institutional-holders/personalis-inc-71535d106) | COM | 2,550,000 | $34.2 million | +950,000 |
| [Grail Inc](https://specstream.ai/data/institutional-holders/grail-inc-384747101) | COM | 480,000 | $32.8 million | +250,000 |
| [Guardant Health Inc](https://specstream.ai/data/institutional-holders/guardant-health-inc-40131m109) | COM | 185,000 | $27.8 million | -130,000 |
| [Maze Therapeutics Inc](https://specstream.ai/data/institutional-holders/maze-therapeutics-inc-578784100) | COM | 843,857 | $25.2 million | +85,000 |
| [Hims & Hers Health Inc](https://specstream.ai/data/institutional-holders/hims-hers-health-inc-433000106) | COM CL A | 700,000 | $24.3 million | No change |
| [Alnylam Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/alnylam-pharmaceuticals-inc-02043q107) | COM | 75,000 | $22.6 million | No change |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 3,250,000 | $22.1 million | No change |
| [Agomab Therapeutics NV](https://specstream.ai/data/institutional-holders/agomab-therapeutics-nv-00860c102) | SPONSORED ADS | 1,550,000 | $20.1 million | No change |
| [Septerna Inc](https://specstream.ai/data/institutional-holders/septerna-inc-81734d104) | COM | 553,268 | $18.5 million | No change |
| [Parabilis Medicines Inc](https://specstream.ai/data/institutional-holders/parabilis-medicines-inc-698955101) | COM | 645,690 | $17.7 million | New |
| [Sionna Therapeutics Inc](https://specstream.ai/data/institutional-holders/sionna-therapeutics-inc-829401108) | COM | 400,000 | $17.6 million | New |
| [Veracyte Inc](https://specstream.ai/data/institutional-holders/veracyte-inc-92337f107) | COM | 276,308 | $16.2 million | No change |
| [Adlai Nortye LTD](https://specstream.ai/data/institutional-holders/adlai-nortye-ltd-00704r109) | SPONSORED ADS | 1,250,000 | $14.4 million | +711,539 |

## New positions in Q2 2026

6 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Parabilis Medicines Inc](https://specstream.ai/data/institutional-holders/parabilis-medicines-inc-698955101) | COM | 645,690 | $17.7 million |
| [Sionna Therapeutics Inc](https://specstream.ai/data/institutional-holders/sionna-therapeutics-inc-829401108) | COM | 400,000 | $17.6 million |
| [Sarepta Therapeutics Inc](https://specstream.ai/data/institutional-holders/sarepta-therapeutics-inc-803607100) | COM | 470,000 | $8.4 million |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 150,000 | $6.9 million |
| [Editas Medicine Inc](https://specstream.ai/data/institutional-holders/editas-medicine-inc-28106w103) | COM | 445,000 | $1.4 million |
| [Kardigan Inc](https://specstream.ai/data/institutional-holders/kardigan-inc-485925101) | COM | 50,000 | $1.2 million |

## Positions exited in Q2 2026

3 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Qiagen NV](https://specstream.ai/data/institutional-holders/qiagen-nv-n72482156) | ORD SHARES | 360,000 | $14.4 million |
| [Tempus AI Inc](https://specstream.ai/data/institutional-holders/tempus-ai-inc-88023b103) | CL A | 294,127 | $13.3 million |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 450,000 | $8.4 million |

## Also on SpecStream

- [Casdin Capital, LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1534261/000091957426005491/0000919574-26-005491-index.htm)
- [Casdin Capital, LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/casdin-capital-llc-169579)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Mexican restaurants in New York, New York](https://specstream.ai/data/businesses/mexican-restaurants/new-york-new-york-united-states)
- [Ambulance services in New York, New York](https://specstream.ai/data/businesses/ambulance-services/new-york-new-york-united-states)
- [Georgian restaurants in New York, New York](https://specstream.ai/data/businesses/georgian-restaurants/new-york-new-york-united-states)
- [Rheumatology practices in New York, New York](https://specstream.ai/data/businesses/rheumatology-practices/new-york-new-york-united-states)
- [Computer training centers in New York, New York](https://specstream.ai/data/businesses/computer-training-centers/new-york-new-york-united-states)
- [Metal suppliers in New York, New York](https://specstream.ai/data/businesses/metal-suppliers/new-york-new-york-united-states)
